Luedtke RR - Search Results

1

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.

Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH. Grundt P, et al. Among authors: luedtke rr. J Med Chem. 2005 Feb 10;48(3):839-48. doi: 10.1021/jm049465g. J Med Chem. 2005. PMID: 15689168

2

Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.

Mach RH, Jackson JR, Luedtke RR, Ivins KJ, Molinoff PB, Ehrenkaufer RL. Mach RH, et al. Among authors: luedtke rr. J Med Chem. 1992 Feb 7;35(3):423-30. doi: 10.1021/jm00081a002. J Med Chem. 1992. PMID: 1531364

3

18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.

Mach RH, Luedtke RR, Unsworth CD, Boundy VA, Nowak PA, Scripko JG, Elder ST, Jackson JR, Hoffman PL, Evora PH, et al. Mach RH, et al. Among authors: luedtke rr. J Med Chem. 1993 Nov 12;36(23):3707-20. doi: 10.1021/jm00075a028. J Med Chem. 1993. PMID: 8246241

4

Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.

Huang Y, Luedtke RR, Freeman RA, Wu L, Mach RH. Huang Y, et al. Among authors: luedtke rr. J Med Chem. 2001 May 24;44(11):1815-26. doi: 10.1021/jm0100077. J Med Chem. 2001. PMID: 11356115

5

Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D(2) and D(3) receptors.

Huang Y, Luedtke RR, Freeman RA, Wu L, Mach RH. Huang Y, et al. Among authors: luedtke rr. Bioorg Med Chem. 2001 Dec;9(12):3113-22. doi: 10.1016/s0968-0896(01)00175-4. Bioorg Med Chem. 2001. PMID: 11711286

6

Synthesis of 2-(5-bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)-1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptors.

Mach RH, Huang Y, Freeman RA, Wu L, Blair S, Luedtke RR. Mach RH, et al. Among authors: luedtke rr. Bioorg Med Chem. 2003 Jan 17;11(2):225-33. doi: 10.1016/s0968-0896(02)00341-3. Bioorg Med Chem. 2003. PMID: 12470717

7

N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists.

Newman AH, Cao J, Bennett CJ, Robarge MJ, Freeman RA, Luedtke RR. Newman AH, et al. Among authors: luedtke rr. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2179-83. doi: 10.1016/s0960-894x(03)00389-5. Bioorg Med Chem Lett. 2003. PMID: 12798330

8

Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands.

Mach RH, Huang Y, Freeman RA, Wu L, Vangveravong S, Luedtke RR. Mach RH, et al. Among authors: luedtke rr. Bioorg Med Chem Lett. 2004 Jan 5;14(1):195-202. doi: 10.1016/j.bmcl.2003.09.083. Bioorg Med Chem Lett. 2004. PMID: 14684327

9

Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.

Chu W, Tu Z, McElveen E, Xu J, Taylor M, Luedtke RR, Mach RH. Chu W, et al. Among authors: luedtke rr. Bioorg Med Chem. 2005 Jan 3;13(1):77-87. doi: 10.1016/j.bmc.2004.09.054. Bioorg Med Chem. 2005. PMID: 15582454

10

Synthesis and characterization of selective dopamine D2 receptor antagonists.

Vangveravong S, McElveen E, Taylor M, Xu J, Tu Z, Luedtke RR, Mach RH. Vangveravong S, et al. Among authors: luedtke rr. Bioorg Med Chem. 2006 Feb 1;14(3):815-25. doi: 10.1016/j.bmc.2005.09.008. Epub 2005 Nov 8. Bioorg Med Chem. 2006. PMID: 16288878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters